Bizzell Wins Two 2023 MUSE Creative Awards for Public Health Projects

Bizzell Wins Two 2023 MUSE Creative Awards for Public Health Projects

Bizzell was awarded two 2023 MUSE Creative Awards; a Gold award for a video and Silver award for a publication, both designed to support the National Institute on Drug Abuse Clinical Trials Network Dissemination Initiative, which aims to reduce the gap that exists between the publication of research on treatment of substance use disorders and implementation in clinical practice.

This year, Bizzell received the top honor of a Gold MUSE Creative Award in the Video-Educational category for the Reducing the Risks of Fentanyl in the U.S. This video was created in collaboration with the University of Pennsylvania Center for Addiction Medicine and Policy in response to rising rates of drug overdose deaths involving opioids. The video also stresses that everyone can be a first responder by carrying naloxone.

Bizzell also won a Silver MUSE Creative Award in the Publication category for the What is Fentanyl Infographic. This infographic was produced in response to the more than 80,000 opioid overdose deaths that occurred in 2020 driven by the illegally produced fentanyl that contaminates illegally produced opioids and benzodiazepines, as well as cocaine and synthetic cannabinoids. Additional information is provided regarding the impact of fentanyl on minorities, the need for broad-reaching awareness and education about the risks of fentanyl exposure, the warning signs of a possible overdose, how to reverse an overdose, and the use of naloxone.

About The MUSE Creative Awards

The MUSE Creative Awards is part of the MUSE Awards Program, which was created by the IAA in 2015. IAA’s inception was based on a mission to honor, promote and encourage creativity by providing a new standard of excellence for evaluation media design production and distribution. IAA’s mission has largely shaped MCA’s goal.

Website: MUSE Creative Awards

Recovery: Breaking the Stigma of Addiction

Recovery: Breaking the Stigma of Addiction

By Bizzell Editorial Staff

Deadbeat. Druggie. Drunkard. Hopeless. These words are still part of the stigma associated with the disease of addiction. And, unfortunately, feeling stigmatized can make people with substance use disorders (SUDs) less willing to seek treatment [1]Hadland, S. E., Park, T. W., & Bagley, S. M. (2018, May 7) Stigma associated with medication treatment for young adults with opioid use disorder: a case series. Addict Sci Clin Practice, 13(1),15. doi: 10.1186/s13722-018-0116-2. PMID: 29730987; PMCID: PMC5937046.. September is Recovery Month, a time dedicated to inspiring hope and raising awareness that recovery from SUDs is possible. This month carries significant meaning for many individuals, families, and communities as a time to honor those recovering from the disease. Those in recovery serve as beacons of hope, shining light on the many challenges faced by millions and highlighting the successes achieved through resilience, determination, and support. Breaking down the stigma associated with SUDs is a vital purpose of celebrating Recovery Month.

Stigma is the prejudicial attitudes and discrimination that people battling SUDs often face. Examples of stigmatic behavior can include inaccurate or unfounded beliefs that people with SUDs are dangerous, incapable of managing treatment, have moral or value failures, or are otherwise at fault for their condition. The Johns Hopkins School of Medicine is removing these barriers by providing guidance and resources to help families navigate existing stigmas and help them avoid perpetuating negative stereotypes. By openly discussing recovery pathways and sharing stories of healing, we can foster an environment where people feel safe to ask for help and access needed support.

According to the National Institute on Drug Addiction (NIDA), stigma affects people with from SUDs by:

  • Reducing the willingness of individuals to seek treatment. 
  • Leading others to feel pity, fear, anger, and a desire for social distance from the person due to stereotypes. 
  • Influencing language, e.g., “alcoholic,” that negatively impacts the perceptions of healthcare providers.  

Shatterproof is a leading national organization dedicated to combating the stigmatizing effects of addiction. They share best practices and resources to positively impact individuals and families grappling with addiction. Examples include:

  1. Change your Language
  2. Take a Pledge
  3. Crisis Resources
  4. Resources for Family & Friends
  5. Resources for Peers
  6. Treatment Resources
  7. Resources for Loss

Recovery Month also sheds light on the significance of accessible and effective treatment options for SUDs. Advocates use this month to raise awareness about the importance of evidence-based quality care, early intervention, harm reduction and the elimination of barriers to treatment. Addiction is a condition that can have a devastating impact on young adults, but it is often not treated effectively.

According to the 2021 National Survey on Drug Use and Health, 94 percent of people aged 12 or older with a substance use disorder did not receive any treatment. Nearly all those with a substance use disorder who were not treated at a specialty facility did not believe that they needed treatment. Organizations such as Young People In Recovery (YPR) are mobilizing efforts to address the imbalance in care. YPR embraces all pathways to recovery including 12-step, harm reduction, medication-assisted treatment, and others to help young adults struggling with addiction.

Bizzell is committed to supporting those in their recovery journey. Earlier this year, we published “Peer Recovery Support Services: A Promising Approach to Combat Substance Use Disorders.” This spotlight describes how peer recovery support services are used to extend the capacity of healthcare workers and to offer ongoing SUD treatment. Bizzell continues to partner with federal agencies to address these issues through a variety of avenues. Through our work with NIDA’s Clinical Trials Network, we produced online educational resources on topics related to screening, fentanyl overdose prevention, and treatment for methamphetamine use disorder.

As September unfolds, remember that healing is possible, and hope is ever-present. Recovery Month encourages us to look beyond the challenges and setbacks, focusing instead on the strength and resilience that lie within each individual and their families and communities. Here are four things you can do to help #StoptheStigma of addiction:

  1. Educate yourself and others about addiction and recovery. The more people understand about addiction, the less likely they are to stigmatize those in recovery.
  2. Use person-first language. Instead of saying “addict” or “alcoholic,” say “person with an addiction” or “person in recovery” to focus on the person, not their condition.
  3. Challenge stigma when you see it. If you hear someone making a negative comment about addiction or recovery, use the opportunity to educate them about how their comments are harmful and offer a more accurate perspective.
  4. Be supportive. Let people facing SUDs know that you are there for them and consider offering practical help, such as rides to meetings or childcare.

References:

[1] Hadland, S. E., Park, T. W., & Bagley, S. M. (2018, May 7) Stigma associated with medication treatment for young adults with opioid use disorder: a case series. Addict Sci Clin Practice, 13(1),15. doi: 10.1186/s13722-018-0116-2. PMID: 29730987; PMCID: PMC5937046.

Senior Associates at Bizzell Co-author NIDA Report on Improving Adolescent Health

Senior Associates at Bizzell Co-author NIDA Report on Improving Adolescent Health

According to numerous reports, it takes roughly 17 years [1] for research findings to find their way into routine clinical practice, depriving adults, and children of timely and effective therapeutic care. The improvement of adolescent health ultimately depends on access to timely research and scientific findings from the National Institute on Drug Abuse (NIDA) to better educate health care professionals, policymakers, adolescents, and their families. The “National Institute of Drug Abuse: Dissemination of Scientific Knowledge to Improve Adolescent Health” report spotlights NIDA’s vigorous efforts to accomplish the dissemination of evidence-based information achieved through varying approaches to diverse and targeted audiences; more specifically on substance use disorders (SUD) in the adolescent population.

The NIDA Clinical Trials Network Dissemination Initiative contract, held by Bizzell US, is overseen by co-authors Dr. Todd Mandell and Kenyatta Crenshaw. Within the report, the co-authors share evidence-based educational resources and materials developed to reduce the persistent gap between the publication of research findings on the treatment of SUDs and best practices for implementation and adoption in clinical practice. Dr. Mandell and Ms. Crenshaw also address the Mentor Facilitated Training Program (MFT), which is part of the NIDA Clinical Trials Network Dissemination Initiative contract. An overview of the MFT program is provided in the article, demonstrating how trainees in the field of substance use are encouraged to expand their depth of knowledge by the 1) identification of gaps in substance abuse training; and 2) dissemination of NIDA-sponsored, evidence-based resources/tools to their peers. The study was published in the Child and Adolescent Psychiatric Clinics of North American Volume 32, Issue 1, January 2023.

“I would like to congratulate Dr. Mandell and Ms. Crenshaw, and the other contributing authors, on the publication of the report, the recommendations are another imperative step to ensuring that the dissemination and access to critical data and tools is widely accessible to the public health community” said Anton C. Bizzell, MD, Chairman & CEO of Bizzell.

[1] Morris ZS, Wooding S, Grant J. The answer is 17 years, what is the question: understanding time lags in translational research. J R Soc Med 2011;104(12): 510–20. Accessed December 14, 2021.

About Bizzell US

Established in 2010, Bizzell US is a U.S. Small Business Administration (SBA) HUBZone-certified strategy, consulting, and technology firm with a mission to improve lives and accelerate change. Bizzell US develops innovative solutions to some of the most critical issues of our time such as health care services equity, global health, workforce innovation, and other urgent needs facing the world. Under the leadership and vision of founder, Anton C. Bizzell, MD, the company has grown into a thriving firm, headquartered in New Carrollton, Maryland, with staff and offices in various regions around the country, including California, Colorado, Connecticut, Oklahoma, and Georgia, and globally in Africa, Asia, and Central America. Learn more about how we develop data-driven, research-informed, innovative solutions to complex, real-world challenges. Learn more at www.BizzellUS.com

Utilizing Behavioral Therapy to Address Stimulant Use Disorder

Utilizing Behavioral Therapy to Address Stimulant Use Disorder

Bizzell US, in partnership with The University of Vermont’s Center on Rural Addiction has produced an interactive educational video for clinicians and practitioners highlighting Contingency Management options for addressing stimulant use disorders.

With rural stimulant overdoses now higher than in urban counties (6.7 vs 4.8 per 100,000.) [1] Hedegaard H, Spencer MR. Urban–rural differences in drug overdose death rates, 1999–2019. NCHS Data Brief, no 403. Hyattsville, MD: National Center for Health Statistics. 2021. DOI: https://dx.doi.org/10.15620/cdc:102891, a renewed focus on combating addiction within these remote communities has taken on a new sense of urgency. “This video adds an important, well studied tool for addressing stimulant use disorder,” said Dr. Todd Mandell of Bizzell US who specializes in substance use and mental health and who was the lead producer of the educational video.

According to the Centers for Disease Control and Prevention (CDC), in 2018, 40% of all overdose deaths were attributed to stimulate use. Until recently there have not been medical treatment alternatives for practitioners treating patients with stimulant use disorder which makes the use of Contingency Management even more urgent.

The video highlights the history of the development of Contingency Management and stresses the key components of a successful program.

To view the educational video please visit: http://uvmcm.modernepic.net

[1] Hedegaard H, Spencer MR. Urban–rural differences in drug overdose death rates, 1999–2019. NCHS Data Brief, no 403. Hyattsville, MD: National Center for Health Statistics. 2021. DOI: https://dx.doi.org/10.15620/cdc:102891